Translation of Randomised Controlled Trial Findings into
Clinical Practice: Comparison of Olanzapine and Valproate in the EMBLEM Study
Pharmacopsychiatry, 07/09/09
- Novick D et al. - The EMBLEM results support those of the RCT, which suggest that olanzapine monotherapy seems to be more effective than valproate monotherapy in the treatment of acute mania.
- EMBLEM (European Mania in Bipolar Evaluation of Medication) was a 2-year, prospective, observational study of health outcomes associated with the treatment of mania.
- Severity of mania and depression were assessed at baseline and 6 weeks using the YMRS and the 5-item version of the HAMD, respectively.
- 621 patients were analysed (n=107 valproate, n=514 olanzapine).
- Both groups improved from baseline to 6 weeks in mean YMRS and HAMD-5 total scores, with greater mean improvements in the olanzapine compared with the valproate group.
- Olanzapine was associated with more weight gain and less gastrointestinal difficulties than valproate.
No comments:
Post a Comment